INOVIO PHARMACEUTICALS INC shareholders Q2 2023

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

INOVIO PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 182,297$81,3960.05%
Y-Intercept (Hong Kong) Ltd 633,613$282,9080.03%
GMT CAPITAL CORP 1,513,500$675,7780.03%
Cedar Brook Financial Partners, LLC 130,522$58,2780.01%
CTC Alternative Strategies, Ltd. 22,000$9,8230.01%
Arlington Capital Management, Inc. 27,735$12,3840.01%
Keystone Financial Group 106,397$47,5090.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,147,319$958,7780.01%
Point72 Middle East FZE 500,624$223,5290.01%
Hennion & Walsh Asset Management, Inc. 195,853$870.01%
Ergoteles LLC 244,500$109,1690.01%
D. E. Shaw & Co., Inc. 7,602,133$3,394,3530.00%
TUDOR INVESTMENT CORP ET AL 553,484$247,1310.00%
Renaissance Technologies 5,436,281$2,4270.00%
Mayflower Financial Advisors, LLC 30,953$13,8210.00%
Greenwich Wealth Management LLC 33,500$150.00%
Qube Research & Technologies Ltd 944,190$421,5810.00%
Virtu Financial LLC 47,902$210.00%
S.A. Mason LLC 3,750$3,0750.00%
TWO SIGMA INVESTMENTS, LP 1,798,240$802,9140.00%
External links

This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q2 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.